Month: April 2021

The Annual General Meeting will be broadcasted live by the Company Shareholders are invited to vote at the General Meeting either by mail or by proxy Marseille, France, April 21, 2021 (GLOBE NEWSWIRE) —  Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”) will hold its Annual General Meeting of Shareholders (“AGM”) at 11:00 a.m. CET on May 28, 2021. The Annual General Meeting will be broadcasted live. The procedures for holding the AGM have been adapted in accordance with French Ordinance No. 2020-321 of 25 March 2020 (as modified by French Ordinance n°2020-1497 of December 2, 2020) and French Decree No. 2020-418 of April 10, 2020 (as modified by French Decree No. 2020-1614 of December 18, 2020), extended by French Decree No. 2021-55 of March 9, 2021. At the date of this publication,...

L’Assemblée Générale sera retransmise en direct par la Société Les actionnaires sont invités à voter à l’Assemblée Générale par correspondance ou par procuration Marseille, France, 21 avr. 2021 (GLOBE NEWSWIRE) — Innate Pharma SA (Euronext Paris : IPH – ISIN : FR0010331421 ; Nasdaq : IPHA) (« Innate » ou la « Société ») annonce la tenue de son Assemblée Générale annuelle, retransmise en direct le 28 mai 2021, à 11h00 CET. Les modalités de tenue de l’Assemblée Générale annuelle ont été adaptées conformément à l’ordonnance n°2020-321 du 25 mars 2020 (telle que modifiée par l’ordonnance n°2020-1497 du 2 décembre 2020) et au décret n°2020-418 du 10 avril 2020 (tel que modifié par le décret n° 2020-1614 du 18 décembre 2020), prorogés par le décret n°2021-255 du 9 mars 2021. En effet, à la date de la présente publication, des mesures...

Acacia Pharma Becomes New Industry Supporter of the American Society of Anesthesiologists Cambridge, UK and Indianapolis, US – 21 April 2021, 07:00 CEST: Acacia Pharma Group plc (“Acacia Pharma”, the “Group” or the “Company”) (EURONEXT: ACPH), a hospital pharmaceutical company focused on the development and commercialization of new products aimed at improving the care of patients undergoing significant treatments such as surgery, other invasive procedures or cancer chemotherapy, is proud to be named a new Industry Supporter of the American Society of Anesthesiologists (“ASA” or the “Society”). Launched in 2010, ASA’s Industry Supporter Program is limited to ten organizations. Participation is intended for companies who want to stand apart by showcasing high-level commitment to the education of physician anesthesiologists, the anesthesia...

Royal Vopak: Interim Update Q1 2021In EUR millions Q1 2020 Q4 2019 Q1 2019Revenues 300.1 303.7 296.9       Results -excluding exceptional items-      Group operating profit before depreciation and amortization (EBITDA) 200.4 188.8 200.2Group operating profit (EBIT) 121.3 108.6 127.0Net profit attributable to holders of ordinary shares 73.1 56.8 82.7Earnings per ordinary share (in EUR) 0.58 0.46 0.65       Results -including exceptional items-      Group operating profit before depreciation and amortization (EBITDA) 200.4 159.8 198.5Group operating profit (EBIT) 121.3 79.6 125.3Net profit attributable to holders of ordinary shares 73.1 24.0 81.0Earnings per ordinary share (in EUR) 0.58 0.20 0.64       Cash flows from operating activities (gross) 124.0 268.8 142.7Cash flows from investing...

The Annual General Meeting will be broadcasted live by the Company Shareholders are invited to vote at the General Meeting either by mail or by proxy MARSEILLE, France, April 21, 2021 (GLOBE NEWSWIRE) — Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”) will hold its Annual General Meeting of Shareholders (“AGM”) at 11:00 a.m. CET on May 28, 2021. The Annual General Meeting will be broadcasted live. The procedures for holding the AGM have been adapted in accordance with French Ordinance No. 2020-321 of 25 March 2020 (as modified by French Ordinance n°2020-1497 of December 2, 2020) and French Decree No. 2020-418 of April 10, 2020 (as modified by French Decree No. 2020-1614 of December 18, 2020), extended by French Decree No. 2021-55 of March 9, 2021. At the date of this publication,...

(2021-04-21) Kitron today reported quarterly figures showing strong growth within the market sectors Electrification and Industry. Kitron’s revenue for the first quarter was NOK 938 million, an increase of 7 per cent compared to last year. Profitability expressed as EBIT margin was 7.0 per cent in the first quarter, compared to 6.7 per cent in the same quarter last year. Peter Nilsson, Kitron’s CEO, comments:“We continue to capitalize on two of the most fundamental changes in the global economy: the move to renewable energy and electrification and the rapid growth in machine-to-machine communications.The demand is very strong. However, as the general material supply situation is challenging, Kitron’s operations will have to be flexible to deliver the demand.In general, the first quarter demonstrates that Kitron’s growth follows...

The Panevezys Regional Court by the ruling dated 20 April 2021 in the case of payment of the interest calculated by the Competition Council of the Republic of Lithuania for the whole period of judicial proceedings when the Company litigated the fine imposed on the Company by the Competition Council has left the court ruling by the Panevezys Chamber of the Panevezys District Court unaffected. The Company is reviewing the motives set out in the court ruling and will make the decision on appealing to the Supreme Court of Lithuania in the nearest future. In the opinion of the Company, even after the ruling by the Panevezys Regional Court there are ambiguities remaining in respect of practical application of the rules for interest calculation provided for in the Law on Competition of the Republic of Lithuania. Therefore, the Company thinks...

2021 m. balandžio 20 d. nutartimi Panevėžio apygardos teismas byloje dėl LR Konkurencijos tarybos priskaičiuotų palūkanų už visą teisminio nagrinėjimo, kurio metu Bendrovė ginčijo Konkurencijos tarybos Bendrovei skirtą baudą, laikotarpį paliko nepakeistą Panevėžio apylinkės teismo Panevėžio rūmų nutartį. Bendrovė analizuoja nutartyje išdėstytus teismo motyvus ir artimiausiu metu priims sprendimą dėl kreipimosi į Lietuvos Aukščiausiąjį Teismą. Bendrovės nuomone, net ir po Panevėžio apygardos teismo nutarties išlieka neaiškumų dėl LR Konkurencijos įstatyme numatytų palūkanų skaičiavimo taisyklių taikymo praktikoje. Todėl, Bendrovė mano, kad kasacinio teismo pozicija šioje byloje būtų svarbi ir suformuotų reikšmingą precedentą ateities situacijoms. Daugiau informacijos:Generalinis direktoriusEgidijus UrbonasTel.: (8-45) 505 503

In the 1stquarter of 2021, the spread of coronavirus continued to affect our ways of working in Tallinna Vesi. Despite the changes made in the work arrangements, the company delivered excellent results for a number of parameters. We are pleased to see consistently high performance in the quality of drinking water and customer service. Cold temperatures in the beginning of the year affected both the level of leakages in the water network as well as the time it took to fix those. High-quality drinking water Water quality in the first three months of the year was 100% compliant with all quality requirements. This means that all the 893 water samples taken from the network during the first quarter met the strict water quality standards. Excellent drinking water quality in the network has been ensured by the efficient management of water treatment...

2021. aasta esimeses kvartalis mõjutas koroonaviiruse levik jätkuvalt töökorraldust Tallinna Vees. Töökorralduses tehtud muudatustest hoolimata saavutasime väga head tulemused mitmete näitajate osas. Meid rõõmustab püsivalt väga hea veekvaliteet ning kõrgel tasemel klienditeenindus. Aasta alguse külmakraadid mõjutasid nii lekete taset veevõrgus kui ka avariitööde teostamise kiirust. Kvaliteetne joogivesi Kraanivee kvaliteet oli 2021. aasta esimeses kvartalis 100% kõigi kvaliteedinõuetega kooskõlas. See tähendab, et kõik võetud veeproovid vastasid veekvaliteedile seatud rangetele normidele. Esimeses kvartalis võeti kokku 893 veeproovi. Suurepärast joogivee kvaliteeti aitasid tagada tõhus veepuhastus, ennetavad hooldustööd veevõrgul ja toorvee madal temperatuur. Töötame pidevalt selle nimel, et veekatkestusi tekiks nii vähe, kui võimalik,...